Insulin, metformin do not reduce inflammatory biomarkers for diabetes patients
Wednesday, September 16, 2009 - 08:14
in Health & Medicine
In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study in the 16 September issue of JAMA...